Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette–Guérin instillation in non-muscle-invasive bladder cancer: a network meta-analysis

• Published in: Frontiers in oncology Vol. 13; p. 1164932
• Main Authors: Zeng, Na, Xu, Meng-Yao, Sun, Jian-Xuan, Liu, Chen-Qian, Xu, Jin-Zhou, An, Ye, Zhong, Xing-Yu, Ma, Si-Yang, He, Hao-Dong, Xia, Qi-Dong, Wang, Shao-Gang
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 2023
• Subjects: adjuvant therapy; BCG; HIVEC; hyperthermia intravesical chemotherapy; network meta-analysis; non-muscle-invasive bladder cancer; Oncology; adjuvant therapy; HIVEC; network meta-analysis; hyperthermia intravesical chemotherapy; non-muscle-invasive bladder cancer; BCG

With the shortage of bacillus Calmette-Guérin (BCG) vaccine, it is important to find an alternative to BCG instillation, which is the most commonly used adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC) patients after transurethral resection of bladder tumor treatment (TURBt) to dela...